Article

The interplay between CB <sub>2</sub> and NMDA receptors in Parkinson’s disease

2025-01-20

Abstract excerpt

Parkinson’s disease (PD) is a progressive neurological disorder that affects movement, causing symptoms such as tremors, stiffness, slowness, and balance problems due to the degeneration of dopamine-producing neurons in the brain. Nowadays there is no cure for PD. Alpha synuclein (α-syn) aggregates, which are a hallmark of PD, are known to induce microglial activation, specifically the detrimental M1 microglial ph...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3383ec51-0a0e-589e-905c-a8699844f9d4
DOI: 10.1101/2025.01.20.633878

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The interplay between CB <sub>2</sub> and NMDA receptors in Parkinson’s diseaseDOI 10.1101/2025.01.20.633878Read

Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathySemantic proximity Read

Microglial Phenotypes and Their Relationship to the Cannabinoid System: Therapeutic Implications for Parkinson's Disease.Semantic proximity Read

Immunoregulation of Microglia M2 polarization is an unrecognized physiological function of α -SynucleinSemantic proximity Read

Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death.Semantic proximity Read

Cannabinoid CB2 receptors in the mouse brain: relevance for Alzheimer’s diseaseSemantic proximity Read

Pathologic α-Synuclein-NOD2 Interaction and RIPK2 Activation Drives Microglia-Induced Neuroinflammation in Parkinson’s DiseaseSemantic proximity Read

Cannabinoid receptor CB2 ablation protects against TAU induced neurodegenerationSemantic proximity Read

Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson´s diseaseSemantic proximity Read

Cannabidivarin alleviates α‐synuclein aggregation via DAF ‐16 in Caenorhabditis elegansSemantic proximity Read

α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes.Semantic proximity Read

Microglial Activation Contributes to Cognitive Impairments in Rotenone-induced Mouse Parkinson’s Disease ModelSemantic proximity Read

An enquiry to the role of CB1 receptors in neurodegenerationSemantic proximity Read